Literature DB >> 27466283

JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

András Zeke1, Mariya Misheva2, Attila Reményi3, Marie A Bogoyevitch4.   

Abstract

The c-Jun N-terminal kinases (JNKs), as members of the mitogen-activated protein kinase (MAPK) family, mediate eukaryotic cell responses to a wide range of abiotic and biotic stress insults. JNKs also regulate important physiological processes, including neuronal functions, immunological actions, and embryonic development, via their impact on gene expression, cytoskeletal protein dynamics, and cell death/survival pathways. Although the JNK pathway has been under study for >20 years, its complexity is still perplexing, with multiple protein partners of JNKs underlying the diversity of actions. Here we review the current knowledge of JNK structure and isoforms as well as the partnerships of JNKs with a range of intracellular proteins. Many of these proteins are direct substrates of the JNKs. We analyzed almost 100 of these target proteins in detail within a framework of their classification based on their regulation by JNKs. Examples of these JNK substrates include a diverse assortment of nuclear transcription factors (Jun, ATF2, Myc, Elk1), cytoplasmic proteins involved in cytoskeleton regulation (DCX, Tau, WDR62) or vesicular transport (JIP1, JIP3), cell membrane receptors (BMPR2), and mitochondrial proteins (Mcl1, Bim). In addition, because upstream signaling components impact JNK activity, we critically assessed the involvement of signaling scaffolds and the roles of feedback mechanisms in the JNK pathway. Despite a clarification of many regulatory events in JNK-dependent signaling during the past decade, many other structural and mechanistic insights are just beginning to be revealed. These advances open new opportunities to understand the role of JNK signaling in diverse physiological and pathophysiological states.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27466283      PMCID: PMC4981676          DOI: 10.1128/MMBR.00043-14

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  515 in total

1.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.

Authors:  Charles R Sweet; Joseph Conlon; Douglas T Golenbock; Jon Goguen; Neal Silverman
Journal:  Cell Microbiol       Date:  2007-06-30       Impact factor: 3.715

3.  Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.

Authors:  L K Busch; G A Bishop
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

5.  Structure and dynamics of the MKK7-JNK signaling complex.

Authors:  Jaka Kragelj; Andrés Palencia; Max H Nanao; Damien Maurin; Guillaume Bouvignies; Martin Blackledge; Malene Ringkjøbing Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

6.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

7.  A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1.

Authors:  Hidehiko Inomata; Yoshitaka Nakamura; Akira Hayakawa; Hiroyuki Takata; Toshiharu Suzuki; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

8.  JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation.

Authors:  Ester Sánchez-Tilló; Mónica Comalada; Jordi Xaus; Consol Farrera; Annabel F Valledor; Carme Caelles; Jorge Lloberas; Antonio Celada
Journal:  J Biol Chem       Date:  2007-03-02       Impact factor: 5.157

9.  Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation.

Authors:  Christopher J Staples; David M Owens; Jana V Maier; Andrew C B Cato; Stephen M Keyse
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

10.  Defective T cell differentiation in the absence of Jnk1.

Authors:  C Dong; D D Yang; M Wysk; A J Whitmarsh; R J Davis; R A Flavell
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  140 in total

1.  Allosteric Modulation of JNK Docking Site Interactions with ATP-Competitive Inhibitors.

Authors:  Chloe K Lombard; Audrey L Davis; Takayuki Inukai; Dustin J Maly
Journal:  Biochemistry       Date:  2018-09-25       Impact factor: 3.162

2.  Role of Caenorhabditis elegans AKT-1/2 and SGK-1 in Manganese Toxicity.

Authors:  Tanara V Peres; Leticia P Arantes; Mahfuzur R Miah; Julia Bornhorst; Tanja Schwerdtle; Aaron B Bowman; Rodrigo B Leal; Michael Aschner
Journal:  Neurotox Res       Date:  2018-06-07       Impact factor: 3.911

Review 3.  When one becomes many-Alternative splicing in β-cell function and failure.

Authors:  Maria Inês Alvelos; Jonàs Juan-Mateu; Maikel Luis Colli; Jean-Valéry Turatsinze; Décio L Eizirik
Journal:  Diabetes Obes Metab       Date:  2018-09       Impact factor: 6.577

4.  ZnT7 RNAi favors RafGOFscrib-/--induced tumor growth and invasion in Drosophila through JNK signaling pathway.

Authors:  Tian Wei; Xiaowen Ji; Yan Gao; Xiaomei Zhu; Guiran Xiao
Journal:  Oncogene       Date:  2021-03-01       Impact factor: 9.867

5.  RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization.

Authors:  Giel Tanghe; Corinne Urwyler-Rösselet; Philippe De Groote; Emmanuel Dejardin; Pieter-Jan De Bock; Kris Gevaert; Peter Vandenabeele; Wim Declercq
Journal:  Cell Mol Life Sci       Date:  2018-02-12       Impact factor: 9.261

6.  Microarray analysis reveals a potential role of lncRNA expression in remote ischemic preconditioning in myocardial ischemia-reperfusion injury.

Authors:  Zhiling Lou; Weijia Wu; Ruiheng Chen; Jie Xia; Haochun Shi; Hanwei Ge; Jiyang Xue; Hanlei Wang; Zhiyong Lin; Maoping Chu; Qifeng Zhao
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

7.  Expression and potential mechanism of metabolism-related genes and CRLS1 in non-small cell lung cancer.

Authors:  Hai-Ming Feng; Ye Zhao; Jian-Ping Zhang; Jian-Hua Zhang; Peng Jiang; Bin Li; Cheng Wang
Journal:  Oncol Lett       Date:  2017-12-12       Impact factor: 2.967

8.  Characterization of the binding mode of JNK-interacting protein 1 (JIP1) to kinesin-light chain 1 (KLC1).

Authors:  T Quyen Nguyen; Magali Aumont-Nicaise; Jessica Andreani; Christophe Velours; Mélanie Chenon; Fernando Vilela; Clémentine Geneste; Paloma F Varela; Paola Llinas; Julie Ménétrey
Journal:  J Biol Chem       Date:  2018-07-19       Impact factor: 5.157

9.  DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK.

Authors:  S Vela; Neira Sainz; María J Moreno-Aliaga; M Solas; María J Ramirez
Journal:  Mol Neurobiol       Date:  2018-06-17       Impact factor: 5.590

10.  High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma.

Authors:  Jian-Dong Shen; Shou-Zhong Fu; Lin-Ling Ju; Yi-Fang Wang; Feng Dai; Zhao-Xiu Liu; Han-Zheng Ji; Jian-Guo Shao; Zhao-Lian Bian
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.